Lymphocytes/NNS
from/IN
CML/NN
patients/NNS
lack/VBP
a/DT
47/CD
kDa/NN
factor/NN
having/VBG
affinity/NN
for/IN
a/DT
genomic/JJ
sterol/NN
regulatory/JJ
sequence/NN
./.

Deranged/VBN
cellular/JJ
cholesterol/NN
homeostasis/NN
has/VBZ
been/VBN
widely/RB
recognized/VBN
in/IN
the/DT
initiation/NN
as/RB
well/RB
as/IN
progression/NN
of/IN
various/JJ
types/NNS
of/IN
cancers/NNS
including/VBG
chronic/JJ
myeloid/JJ
leukaemia/NN
(/(
CML/NN
)/)
./.
=====
Since/IN
the/DT
human/JJ
genomic/JJ
sterol/NN
regulatory/JJ
element/NN
(/(
SRE/NN
)/)
has/VBZ
been/VBN
shown/VBN
to/TO
regulate/VB
various/JJ
key/JJ
genes/NNS
involved/VBN
in/IN
this/DT
phenomenon/NN
,/,
the/DT
present/JJ
study/NN
revealed/VBD
the/DT
existence/NN
of/IN
a/DT
unique/JJ
47/CD
kDa/NN
protein/NN
factor/NN
having/VBG
affinity/NN
for/IN
this/DT
SRE/JJ
sequence/NN
in/IN
lymphocytes/NNS
from/IN
normal/JJ
subjects/NNS
,/,
as/RB
well/RB
as/IN
its/PRP$
absence/NN
in/IN
lymphocytes/NNS
from/IN
untreated/JJ
CML/NN
patients/NNS
./.
=====
However/RB
,/,
this/DT
factor/NN
appeared/VBD
when/WRB
these/DT
CML/NN
patients/NNS
achieved/VBD
complete/JJ
haematological/JJ
remission/NN
(/(
CHR/NN
)/)
through/IN
alpha-interferon/NN
therapy/NN
./.
=====
Furthermore/RB
,/,
an/DT
inverse/JJ
relationship/NN
was/VBD
also/RB
observed/VBN
between/IN
the/DT
LDL/NN
receptor/NN
gene/NN
expression/NN
at/IN
the/DT
transcriptional/JJ
level/NN
and/CC
the/DT
binding/NN
affinity/NN
of/IN
this/DT
47/CD
kDa/NN
protein/NN
factor/NN
to/TO
the/DT
SRE/NN
sequence/NN
./.
=====
Based/VBN
upon/IN
these/DT
results/NNS
we/PRP
propose/VBP
that/IN
this/DT
factor/NN
may/MD
have/VB
a/DT
role/NN
in/IN
pathophysiology/NN
of/IN
chronic/JJ
myeloid/JJ
leukaemia/NN
./.